Loading
Loading
Madrigal Pharmaceuticals ceo salary
Bill Sibold, President and Chief Executive Officer of MADRIGAL PHARMACEUTICALS, INC. (MDGL), received $19,206,341 ($19.2M) in total compensation for FY2025, up 57.2% from the prior year. Stock awards of $12,297,850 were the largest component. Figures come from MADRIGAL PHARMACEUTICALS, INC.'s DEF 14A filed 28 Apr 2026 (accession 0001308179-26-000352).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001308179-26-000352). These figures come from MADRIGAL PHARMACEUTICALS, INC.'s DEF 14A filed 28 Apr 2026 (accession 0001308179-26-000352).
| Component | Amount |
|---|---|
| Salary | $918,531 |
| Stock awards | $12,297,850 |
| Option awards | $4,537,146 |
| Cash incentive | $1,438,814 |
| Other | $14,000 |
| Total | $19,206,341 |
FAQ
See also: MDGL ticker page